|Videos|December 20, 2019

Management of HER2 Expression in Breast Cancer

Ian E. Krop, MD, PhD, provides insight on HER2 expression in breast cancer, treatment for blocking HER2, and the management of newly diagnosed HER2+ metastatic breast cancer with T-DM1.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.

What Does Minimal Residual Disease Mean?

ByDr. Dickran Kazandjian

December 11th 2025

The Emmy-winning journalist and author delivered the keynote address at the inaugural Blood Cancer Heroes event.

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

BySuleika Jaouad

December 10th 2025

In a recent interview with CURE, Dr. Kai Tsao discussed treatment advancements for patients with prostate cancer.

Breaking Down the Prostate Cancer Treatment Renaissance

ByDr. Kai Tsao

December 9th 2025

Dr. Robert Orlowski, chairman, Ad Interim; director of Myeloma; and professor of Medicine in the Departments of Lymphoma/Myeloma and Experimental Therapeutics within the Division of Cancer Medicine at the University of Texas MD Anderson Cancer Center in Houston.

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

ByDr. Robert Orlowski

December 8th 2025

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

ByDr. James Berenson

December 7th 2025

Management of HER2 Expression in Breast Cancer

Newsletter

Related Content

What Does Minimal Residual Disease Mean?

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

Breaking Down the Prostate Cancer Treatment Renaissance

Single-Drug Approach Explored for Newly Diagnosed Multiple Myeloma

Real-Time Text Tool Tracks Quality of Life in Myeloma Care

Trending on CURE

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

Giredestrant Improves Outcomes in ER+/HER2– Breast Cancer

Tukysa Combo Boosts Frontline Maintenance in Advanced HER2+ Breast Cancer

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

Trodelvy Not Associated With Significant Progression Improvements in HR+/HER2– mBC